STOCK TITAN

Cognex Reports Record Quarterly Revenue

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Cognex Corporation (NASDAQ: CGNX) reported record revenue of $284.8 million for Q3-21, a 13% increase year-over-year and a 6% increase from Q2-21. Despite profitability with a net income of $78.9 million and an operating margin of 31%, the company faces challenges such as global chip shortages affecting revenue growth and increased operational costs. In the first nine months, revenue grew by 35% to $793 million, while net income surged 112% to $226.3 million. For Q4-21, revenue is expected between $210 million and $230 million, with anticipated gross margins in the low-70% range.

Positive
  • Record quarterly revenue of $284.8 million, highest in 40 years.
  • Net income increased to $78.9 million, showing profitability.
  • Operating margin at 31%, above long-term target of 30%.
  • Year-to-date revenue growth of 35% compared to 2020.
Negative
  • Net income decreased by 10% compared to Q3-20.
  • Gross margin declined to 70% from 76% in Q3-20 due to unfavorable revenue mix.
  • Supply chain constraints beginning to impact revenue growth.
  • Anticipated Q4-21 revenue is roughly flat compared to high-growth Q4-20.

NATICK, Mass.--(BUSINESS WIRE)-- Cognex Corporation (NASDAQ: CGNX) today reported financial results for the third quarter of 2021 which included record quarterly revenue. Table 1 below shows selected financial data for Q3-21 compared with Q3-20 and Q2-21, and for the nine months of 2021 compared with the same period in 2020.

Table 1
(Dollars in thousands, except per share amounts)

 

 

 

 

 

Revenue

 

 

 

Net Income

 

Net Income

per Diluted

Share

Non-GAAP

Net Income

per Diluted
Share*

Quarterly Comparisons

 

 

 

 

Current quarter: Q3-21

$284,848

$78,900

$0.44

$0.40

Prior year’s quarter: Q3-20

$251,073

$87,506

$0.49

$0.47

Change: Q3-20 to Q3-21

13%

(10)%

(10)%

(15)%

Prior quarter: Q2-21

$269,158

$77,598

$0.43

$0.43

Change: Q2-21 to Q3-21

6%

2%

2%

(7)%

Year-to-Date Comparisons

 

 

 

 

Nine months ended Oct. 3, 2021

$793,033

$226,346

$1.26

$1.20

Nine months ended Sept. 27, 2020

$587,405

$106,841

$0.61

$0.77

Change from first nine months of 2020 to first nine months of 2021

35%

112%

107%

56%

*Non-GAAP net income per diluted share excludes restructuring and other charges that occurred predominantly in Q2-20, and discrete tax adjustments. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.

“We are pleased to report the highest quarterly revenue in our company’s 40-year history, surpassing the prior record set last quarter,” said Robert J. Willett, Chief Executive Officer of Cognex. “We were also highly profitable and reported an operating margin of 31%, which is above our 30% long-term target. And we were able to accomplish these achievements while operating in a very challenging supply environment.”

Mr. Willett continued, “In regard to supply, we believe we have been managing global chip shortages relatively well so far. However, the constraints are beginning to hold back revenue growth and drive cost increases more noticeably. Demand from customers is high and meeting their needs remains our top priority as we work through this situation.”

Details of the Quarter

Statement of Operations Highlights – Third Quarter of 2021

  • Cognex reported record revenue of $285 million for the third quarter, which represents an increase of 13% from Q3-20 and 6% from Q2-21. As expected, growth in logistics, automotive, and other markets on a year-on-year basis was substantially offset by lower revenue from customers in consumer electronics (Q3-20 included a heavy concentration of electronics revenue that drove substantial growth for the company overall in 2020). The increase in revenue on a sequential basis is due to higher sales to customers in logistics and the timing of revenue from consumer electronics.
  • Gross margin was 70% for Q3-21, 76% for Q3-20, and 75% for Q2-21. The decrease in gross margin, both year-on-year and sequentially, was due to unfavorable revenue mix in Q3-21. In addition, supply chain costs were higher due to global component shortages.
  • Research, Development, & Engineering (RD&E) expenses increased by 14% from Q3-20 and 10% from Q2-21. The increase in RD&E spending, both year-on-year and sequentially, was due to the company’s investment in engineering resources.
  • Selling, General & Administrative (SG&A) expenses increased by 20% from Q3-20 and remained flat with Q2-21. SG&A spending increased over Q3-20 due to higher personnel-related costs (including additional sales headcount), higher incentive compensation costs (including sales commissions and annual company bonus), and the impact of foreign currency exchange rate changes.
  • The effective tax rate was 11% in Q3-21, 14% in Q3-20, and 17% in Q2-21. The effective tax rate was 18% in all periods presented excluding the discrete tax adjustments summarized in Exhibit 2.

Balance Sheet Highlights – October 3, 2021

  • Cognex’s financial position as of October 3, 2021 continued to bestrong, with $985 million in cash and investments and no debt. In the first nine months of 2021, Cognex generated $259 million in cash from operations and $59 million in net proceeds from the exercise of stock options. In addition, the company spent $48 million to repurchase its common stock and paid $32 million in dividends to shareholders. Cognex intends to continue to repurchase shares of its common stock pursuant to its existing stock repurchase program, subject to market conditions and other relevant factors.
  • Inventories at October 3, 2021 increased by $20 million, or 33%, from the end of 2020. Cognex added component inventory to support customer orders and replenished some strategic inventory balances, the cost of which was noticeably higher than in prior periods.

Financial Outlook – Q4 2021

  • Cognex believes revenue in Q4-21 will be between $210 million and $230 million, which is roughly flat at the mid-point compared with a high-growth quarter reported in Q4-20. The company expects to experience a lingering headwind from last year’s high concentration of consumer electronics revenue in the second half of 2020, delayed product sales in Q4-21 because of supply-chain constraints, and low growth in logistics due to the timing of revenue.
  • Gross margin for Q4-21 is expected to be in the low-70% range and below the company’s mid-70% long-term target because of elevated costs, particularly for components and freight.
  • Operating expenses are expected to increase by mid-single digits from Q3-21 due to investments around the company’s growth plans, including additional resources, new product development, and sales and marketing activities.
  • The effective tax rate is expected to be 18%, excluding discrete tax items.

Non-GAAP Financial Measures

  • Exhibit 2 of this news release includes a reconciliation of certain financial measures from GAAP to non-GAAP. Cognex believes these non-GAAP financial measures are helpful because they allow investors to more accurately compare Cognex results over multiple periods using the same methodology that management employs in its budgeting process and in its review of Cognex’s operating results. Non-GAAP presentations exclude certain one-time discrete events, such as discrete tax adjustments (because these costs are outside of Cognex’s normal business operations and not used by management to assess Cognex’s operating results). Additionally, the company excludes restructuring charges, intangible asset impairment charges, and excess and obsolete inventory charges because these charges result from discrete activities, such as specific restructuring actions or acquisitions, that management frequently excludes in evaluating Cognex’s operating results. Cognex does not intend for non-GAAP financial measures to be considered in isolation, or as a substitute for financial information provided in accordance with GAAP.
  • We estimate the tax effect of items identified in the reconciliation by applying the effective tax rate to the pre-tax amount. However, if a specific tax rate or tax treatment is required because of the nature of the item and/or the tax jurisdiction where the item was recorded, we estimate the tax effect by applying the relevant specific tax rate or tax treatment, rather than the effective tax rate.

Analyst Conference Call and Simultaneous Webcast

  • Cognex will host a conference call today at 5:00 p.m. Eastern Daylight Time (EDT). The telephone number is (877) 704-4573 (or (201) 389-0911 if outside the United States). A replay will begin at 8:00 p.m. EDT today and will be available until 11:59 p.m. EDT on Sunday, November 7, 2021. The telephone number for the replay is (877) 660-6853 (or (201) 612-7415 if outside the United States). The access code for both the live call and the replay is 13722693.
  • A real-time audio broadcast of the conference call or an archived recording will be accessible on the Events & Presentations page of the Cognex Investor website: https://www.cognex.com/Investor.

About Cognex Corporation

Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors, and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.

Cognex is the world's leader in the machine vision industry, having shipped more than 3 million image-based products, representing over $8 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.

Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance, the expected impact of the COVID-19 pandemic on our assets, business and results of operations, customer demand and order rates and timing of related revenue, managing supply shortages, future product mix, restructuring and other cost-savings initiatives, research and development activities, sales and marketing activities, new product offerings, capital expenditures, investments, liquidity, dividends and stock repurchases, strategic and growth plans, and estimated tax benefits and expenses and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the impact, duration, and severity of the COVID-19 pandemic; (2) potential disruptions to our business due to restructuring activities; (3) the loss of, or curtailment of purchases by, large customers in the consumer electronics and logistics industries; (4) the reliance on revenue from the automotive industry; (5) the reliance on key suppliers to manufacture and deliver critical components for our products; (6) disruptions in the supply chain, which could impact timely delivery of customer orders, cause customer orders to decrease, or increase costs to fulfill orders, including costs for components or freight; (7) the failure to effectively manage product transitions or accurately forecast customer demand; (8) the inability to design and manufacture high-quality products; (9) the inability to attract and retain skilled employees and maintain our unique corporate culture; (10) the failure to effectively manage our growth; (11) the inability to achieve growth in revenue and profits from the logistics industry; (12) the technological obsolescence of current products and the inability to develop new products; (13) the failure to properly manage the distribution of products and services; (14) the impact of competitive pressures; (15) the challenges in integrating and achieving expected results from acquired businesses; (16) potential disruptions in our business systems; (17) information security breaches and cyber-attacks; (18) the inability to protect our proprietary technology and intellectual property; (19) potential impairment charges with respect to our investments or acquired intangible assets; (20) exposure to additional tax liabilities; (21) fluctuations in foreign currency exchange rates and the use of derivative instruments; (22) our involvement in time-consuming and costly litigation; (23) unfavorable global economic conditions; and (24) economic, political, and other risks associated with international sales and operations; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2020 and Form 10-Q for the fiscal quarter ended October 3, 2021. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.

Exhibit 1

COGNEX CORPORATION
Statements of Operations
(Unaudited)
Dollars in thousands, except per share amounts

 

 

Three-months Ended

 

Nine-months Ended

 

Oct. 3,
2021

 

Jul. 4,
2021

 

Sept. 27,
2020

 

Oct. 3,
2021

 

Sept. 27,
2020

Revenue

$

284,848

 

 

$

269,158

 

 

$

251,073

 

 

$

793,033

 

 

$

587,405

 

Cost of revenue (1)

85,712

 

 

68,432

 

 

59,741

 

 

208,189

 

 

151,261

 

Gross margin

199,136

 

 

200,726

 

 

191,332

 

 

584,844

 

 

436,144

 

Percentage of revenue

70

%

 

75

%

 

76

%

 

74

%

 

74

%

Research, development, and engineering expenses (1)

34,476

 

 

31,302

 

 

30,240

 

 

99,883

 

 

96,583

 

Percentage of revenue

12

%

 

12

%

 

12

%

 

13

%

 

16

%

Selling, general, and administrative expenses (1)

77,113

 

 

76,843

 

 

64,206

 

 

226,380

 

 

193,497

 

Percentage of revenue

27

%

 

29

%

 

26

%

 

29

%

 

33

%

Restructuring charges

 

 

 

 

251

 

 

 

 

15,049

 

Intangible asset impairment charges

 

 

 

 

 

 

 

 

19,571

 

Operating income

87,547

 

 

92,581

 

 

96,635

 

 

258,581

 

 

111,444

 

Percentage of revenue

31

%

 

34

%

 

38

%

 

33

%

 

19

%

Foreign currency gain (loss)

(586)

 

 

(639)

 

 

2,357

 

 

(2,233)

 

 

(310)

 

Investment and other income

1,623

 

 

1,596

 

 

2,317

 

 

4,605

 

 

10,857

 

Income before income tax expense

88,584

 

 

93,538

 

 

101,309

 

 

260,953

 

 

121,991

 

Income tax expense

9,684

 

 

15,940

 

 

13,803

 

 

34,607

 

 

15,150

 

Net income

$

78,900

 

 

$

77,598

 

 

$

87,506

 

 

$

226,346

 

 

$

106,841

 

Percentage of revenue

28

%

 

29

%

 

35

%

 

29

%

 

18

%

 

 

 

 

 

 

 

 

 

 

Net income per weighted-average common and common-equivalent share:

 

 

 

 

 

 

 

 

 

Basic

$

0.45

 

 

$

0.44

 

 

$

0.50

 

 

$

1.28

 

 

$

0.62

 

Diluted

$

0.44

 

 

$

0.43

 

 

$

0.49

 

 

$

1.26

 

 

$

0.61

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common and common-equivalent shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

176,812

 

 

176,626

 

 

173,943

 

 

176,572

 

 

172,881

 

Diluted

180,342

 

 

179,991

 

 

177,138

 

 

180,109

 

 

176,038

 

 

 

 

 

 

 

 

 

 

 

Cash dividends per common share

$

0.060

 

 

$

0.060

 

 

$

0.055

 

 

$

0.180

 

 

$

0.165

 

Cash and investments per common share

$

5.57

 

 

$

5.39

 

 

$

5.80

 

 

$

5.57

 

 

$

5.80

 

Book value per common share

$

8.44

 

 

$

8.09

 

 

$

8.62

 

 

$

8.44

 

 

$

8.62

 

 

 

 

 

 

 

 

 

 

 

(1) Amounts include stock-based compensation expense, as follows:

 

 

 

 

 

 

 

 

 

Cost of revenue

$

366

 

 

$

351

 

 

$

324

 

 

$

965

 

 

$

1,041

 

Research, development, and engineering

3,091

 

 

3,064

 

 

2,815

 

 

10,158

 

 

10,582

 

Selling, general, and administrative

7,157

 

 

7,315

 

 

6,129

 

 

22,230

 

 

20,453

 

Total stock-based compensation expense

$

10,614

 

 

$

10,730

 

 

$

9,268

 

 

$

33,353

 

 

$

32,076

 

 

 

 

 

 

 

 

 

 

 

Exhibit 2

 

COGNEX CORPORATION
Reconciliation of Selected Items from GAAP to Non-GAAP
(Unaudited)
Dollars in thousands, except per share amounts

 

 

Three-months Ended

 

 

Nine-months Ended

 

Oct. 3,
2021

 

Jul. 4,
2021

 

Sept. 27,
2020

 

 

Oct. 3,
2021

 

Sept. 27,
2020

Discrete tax adjustments reconciliation

 

 

 

 

 

 

 

Income before income tax expense (GAAP)

$

88,584

 

 

$

93,538

 

 

$

101,309

 

 

 

$

260,953

 

 

$

121,991

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense (GAAP)

$

9,684

 

 

$

15,940

 

 

$

13,803

 

 

 

$

34,607

 

 

$

15,150

 

Effective tax rate (GAAP)

11

%

 

17

%

 

14

%

 

 

13

%

 

12

%

 

 

 

 

 

 

 

 

 

 

 

Discrete tax benefit related to stock-based compensation

3,250

 

 

1,431

 

 

4,354

 

 

 

9,888

 

 

10,447

 

Discrete tax benefit (expense) related to tax return filings and other

3,012

 

 

(535)

 

 

(129)

 

 

 

2,477

 

 

(3,638)

 

Total discrete tax adjustments

$

6,262

 

 

$

896

 

 

$

4,225

 

 

 

$

12,365

 

 

$

6,809

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense (Non-GAAP)

$

15,946

 

 

$

16,836

 

 

$

18,028

 

 

 

$

46,972

 

 

$

21,959

 

Effective tax rate (Non-GAAP)

18

%

 

18

%

 

18

%

 

 

18

%

 

18

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring and other charges and discrete tax adjustments reconciliation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (GAAP)

$

78,900

 

 

$

77,598

 

 

$

87,506

 

 

 

$

226,346

 

 

$

106,841

 

Excess and obsolete inventory charges

303

 

 

1,111

 

 

603

 

 

 

2,120

 

 

9,386

 

Restructuring charges

 

 

 

 

251

 

 

 

 

 

15,049

 

Intangible asset impairment charges

 

 

 

 

 

 

 

 

 

19,571

 

Tax effect on restructuring and other charges

(55)

 

 

(200)

 

 

(154)

 

 

 

(382)

 

 

(7,921)

 

Discrete tax adjustments

(6,262)

 

 

(896)

 

 

(4,225)

 

 

 

(12,365)

 

 

(6,809)

 

Net income (Non-GAAP)

$

72,886

 

 

$

77,613

 

 

$

83,981

 

 

 

$

215,719

 

 

$

136,117

 

Percentage of revenue (Non-GAAP)

26

%

 

29

%

 

33

%

 

 

27

%

 

23

%

 

 

 

 

 

 

 

 

 

 

 

Net income per diluted weighted-average common and common-equivalent share (GAAP)

$

0.44

 

 

$

0.43

 

 

$

0.49

 

 

 

$

1.26

 

 

$

0.61

 

Per share impact of non-GAAP adjustments identified above

(0.04)

 

 

 

 

(0.02)

 

 

 

(0.06)

 

 

0.16

 

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.40

 

 

$

0.43

 

 

$

0.47

 

 

 

$

1.20

 

 

$

0.77

 

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted-average common and common-equivalent shares outstanding

180,342

 

 

179,991

 

 

177,138

 

 

 

180,109

 

 

176,038

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 3

COGNEX CORPORATION
Balance Sheets
(Unaudited)
Dollars in thousands

 

 

October 3, 2021

 

December 31, 2020

Assets

 

 

 

Cash and investments

$

985,386

 

 

$

767,438

 

Accounts receivable

129,784

 

 

125,696

 

Inventories

81,170

 

 

60,830

 

Property, plant, and equipment

76,882

 

 

79,173

 

Operating lease assets

24,154

 

 

22,582

 

Goodwill and intangible assets

254,581

 

 

259,633

 

Deferred tax assets

420,962

 

 

434,704

 

Other assets

75,884

 

 

50,646

 

 

 

 

 

Total assets

$

2,048,803

 

 

$

1,800,702

 

 

 

 

 

Liabilities and Shareholders' Equity

 

 

 

Accounts payable and accrued expenses

$

107,134

 

 

$

93,534

 

Deferred revenue and customer deposits

37,843

 

 

21,274

 

Operating lease liabilities

26,811

 

 

26,230

 

Income taxes

68,039

 

 

72,551

 

Deferred tax liabilities

302,019

 

 

314,952

 

Other liabilities

13,996

 

 

9,959

 

Shareholders' equity

1,492,961

 

 

1,262,202

 

 

 

 

 

Total liabilities and shareholders' equity

$

2,048,803

 

 

$

1,800,702

 

 

Susan Conway

Investor Relations

+1 508-650-3353

Susan.conway@cognex.com

Source: Cognex Corporation

FAQ

What were Cognex's financial results for Q3 2021?

Cognex reported a record revenue of $284.8 million for Q3 2021, a 13% increase from Q3 2020.

How did Cognex's net income change in Q3 2021?

The net income for Cognex in Q3 2021 was $78.9 million, a decrease of 10% from the previous year's quarter.

What is the forecast for Cognex's revenue in Q4 2021?

Cognex expects Q4 2021 revenue to be between $210 million and $230 million.

What challenges is Cognex facing regarding supply chain?

Cognex is experiencing difficulties due to global chip shortages that are affecting revenue growth and increasing costs.

What is Cognex's operating margin for Q3 2021?

Cognex reported an operating margin of 31% for Q3 2021.

Cognex Corp

NASDAQ:CGNX

CGNX Rankings

CGNX Latest News

CGNX Stock Data

6.18B
171.08M
0.25%
99.48%
1.96%
Scientific & Technical Instruments
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
NATICK